AVITA Medical, Inc. (RCEL) Misses Q1 EPS by 41c

AVITA Medical, Inc. (NASDAQ: RCEL) reported Q1 EPS of ($0.73), $0.41 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $11.1 million versus the consensus estimate of $12.02 million.

For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• William Blair Upgrades Backblaze Inc (BLZE) to Market Perform
• Qualcomm investor day to detail data center plans Wednesday